Clinical Trials Logo

Primiparity clinical trials

View clinical trials related to Primiparity.

Filter by:
  • None
  • Page 1

NCT ID: NCT06119282 Enrolling by invitation - Clinical trials for Cesarean Section Complications

The Effect of Aromatherapy in Women With Primiparous Cesarean Section

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

This study was organized as a randomized controlled trial. The sample was calculated as 120 (Control: 60, Experiment 1:30 Experiment 2:30). Primiparous cesarean section women will be evaluated for pain, postpartum comfort and anxiety levels by using lavender oil, tangerine oil and vetiver oil. The first group will be given inhaler application, the second group will be massage and aromatherapy application. The third group will be the control group.

NCT ID: NCT04536597 Completed - Postpartum Clinical Trials

Quince Seed Jelly and Breast Milk on Nipple Fissures

QSJ
Start date: October 15, 2015
Phase: N/A
Study type: Interventional

Background: In various experimental or clinical studies, it has been reported that the jelly made from the quince seed is effective in healing wounds (attributed to the antioxidants, which increased fibroblast activity and collagen production, facilitated the formation of granulation tissue and increased blood circulation) and has no side effects or contraindications. Purpose: To evaluates the effects of quince seed jelly and breast milk on nipple fissures. Methods: Randomised controlled experimental study.

NCT ID: NCT03506204 Recruiting - Postpartum Clinical Trials

The Pelvic Floor Muscle Function in Chinese Primipara, a One-year Cohort Study

Start date: May 10, 2018
Phase:
Study type: Observational [Patient Registry]

It is a prospective cohort study.The primiparas in six geographic regions of China are recruited to observe the natural recovery of pelvic floor muscle. The pelvic floor muscle function is evaluated at 6 weeks,3 months and 12 months after delivery.

NCT ID: NCT00763672 Completed - Hypertension Clinical Trials

MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study

MOMA
Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether close monitoring of patients with a high sFlt1 plasma level between 25 and 28 weeks of gestation (i.e. at high risk of subsequent preeclampsia) improves maternal and fetal outcomes. The investigator hypothesize that 1/ early screening for preeclampsia by plasmatic sFlt1 will reduce maternal and fetal mortality and morbidity and 2/ a simple urinary PlGF screening will be effective.